Dr. Poornima Ramadas
Claim this profileLSU Health Sciences Center at Shreveport
Studies Lymphoma
Studies Multiple Myeloma
7 reported clinical trials
20 drugs studied
Area of expertise
1Lymphoma
Stage IV
Stage III
13q positive
2Multiple Myeloma
Stage I
Stage II
Stage III
Affiliated Hospitals
Clinical Trials Poornima Ramadas is currently running
Combination Therapy
for Multiple Myeloma
This phase III trial compares the combination of four drugs (daratumumab, bortezomib, lenalidomide and dexamethasone) to the use of a three drug combination (daratumumab, lenalidomide and dexamethasone). Bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as lenalidomide, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Daratumumab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. Anti-inflammatory drugs, such as dexamethasone lower the body's immune response and are used with other drugs in the treatment of some types of cancer. Adding bortezomib to daratumumab, lenalidomide, and dexamethasone may be more effective in shrinking the cancer or preventing it from returning, compared to continuing on daratumumab, lenalidomide, and dexamethasone.
Recruiting2 awards Phase 332 criteria
Oral Azacitidine + R-miniCHOP
for Diffuse Large B-Cell Lymphoma
This phase II/III trial compares the side effects and activity of oral azacitidine in combination with the standard drug therapy (reduced dose rituximab-cyclophosphamide, doxorubicin, vincristine, and prednisone \[R-miniCHOP\]) versus R-miniCHOP alone in treating patients 75 years or older with newly diagnosed diffuse large B cell lymphoma. R-miniCHOP includes a monoclonal antibody (a type of protein), called rituximab, which attaches to the lymphoma cells and may help the immune system kill these cells. R-miniCHOP also includes prednisone which is an anti-inflammatory medication and a combination of 3 chemotherapy drugs, cyclophosphamide, doxorubicin, and vincristine. These 3 chemotherapy drugs, as well as oral azacitidine, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Combining oral azacitidine with R-miniCHOP may shrink the cancer or extend the time without disease symptoms coming back or extend patient's survival when compared to R-miniCHOP alone.
Recruiting1 award Phase 2 & 314 criteria
More about Poornima Ramadas
Clinical Trial Related5 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Poornima Ramadas has experience with
- Lenalidomide
- Dexamethasone
- Venetoclax
- Obinutuzumab
- Oral Azacitidine
- Rituximab
Breakdown of trials Poornima Ramadas has run
Lymphoma
Multiple Myeloma
Plasma Cell Neoplasms
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Poornima Ramadas specialize in?
Poornima Ramadas focuses on Lymphoma and Multiple Myeloma. In particular, much of their work with Lymphoma has involved Stage IV patients, or patients who are Stage III.
Is Poornima Ramadas currently recruiting for clinical trials?
Yes, Poornima Ramadas is currently recruiting for 6 clinical trials in Shreveport Louisiana. If you're interested in participating, you should apply.
Are there any treatments that Poornima Ramadas has studied deeply?
Yes, Poornima Ramadas has studied treatments such as Lenalidomide, Dexamethasone, Venetoclax.
What is the best way to schedule an appointment with Poornima Ramadas?
Apply for one of the trials that Poornima Ramadas is conducting.
What is the office address of Poornima Ramadas?
The office of Poornima Ramadas is located at: LSU Health Sciences Center at Shreveport, Shreveport, Louisiana 71103 United States. This is the address for their practice at the LSU Health Sciences Center at Shreveport.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.